The Janssen Pharmaceutical Companies of Johnson & Johnson Mar 2014 - 2014
Head of Immunology Development
The Janssen Pharmaceutical Companies of Johnson & Johnson Aug 2012 - Mar 2014
Vice President of Immunology, Gastroenterology and Dermatology Development Leader
Centocor Jan 2010 - Aug 2012
Senior Director- Vice President of Immunology, Clinical R and D, Cdtl
Centocor Feb 2004 - Jan 2010
Associate Director  Senior Director, Immunology Development
Centocor Sep 2002 - Feb 2004
Associate Director of Immunology, Medical Affairs
Education:
University of Pennsylvania School of Medicine 1991 - 1995
University of Pittsburgh School of Medicine 1988 - 1991
University of Pennsylvania School of Medicine 1985 - 1988
Davidson College 1977 - 1981
Bachelors, Bachelor of Science
Skills:
Clinical Research Biotechnology Clinical Trials Pharmaceutical Industry Clinical Development Strategic Planning Immunology Dermatology Research Healthcare Microsoft Excel Infectious Diseases Medicine Cancer Powerpoint Hospitals Oncology Life Sciences Medical Affairs
A method of treating an IL-12/23-related disease in a patient using an increasing dosing interval, comprises increasing the dosing interval of IL-12/IL-23 antibody to a patient, wherein the antibody is administered initially and after 4 weeks, after 16 weeks and after 28 weeks, and increasing the dosing interval after 28 weeks to an increased interval, e.g., every 16, 20 or 24 weeks.
License Records
Newman Manly Yeilding
Address:
Ardmore, PA 19003
License #:
MD038019E - Expired
Category:
Medicine
Type:
Medical Physician and Surgeon
Newman Manly Yeilding Iii
License #:
MT014221T - Expired
Category:
Medicine
Type:
Graduate Medical Trainee
News
Janssen Presents Positive Data from Phase 3 UNITI-1 of STELARA as Crohn's Disease Treatment (JNJ)
share these important results from the Phase 3 UNITI-1 induction study, which complement Phase 3 results from the UNITI-2 study and further support regulatory applications submitted seeking approval of STELARA for the treatment of moderately to severely active Crohn's disease," said Newman Yeilding,
Date: Mar 18, 2016
Category: Health
Source: Google
Youtube
Charlie the Zebra, Episode 2-Ground Driving
The next step in 2 1/2 year old Charlie Brown's harness training is Gr...